Phagocytes modulators (, in particular, phagocytes activators) for the treatment and / or prophylaxis of thrombotic, atherothrombotic and / or blood coagulation diseases

摘要

The present invention relates to a pharmaceutical composition comprising an agent which contains the activity of phagocytes modulated, in particular activated. Phagocytes modulation, in particular phagocytes activation, is in particular for the treatment and / or prophylaxis of thrombotic, atherothrombotic and / or blood coagulation diseases. In particular are suitable for this purpose, oxidized oxidation receptors (prepared, for example, from a blood - and / or plasma - product) as well as analogs, derivatives, constitute mimetics, precursors or antagonists of phagocytes activators.